Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2 Suppl):21S-32S.

Antiblastic treatment of haematological malignancies during pregnancy: a crucial decision.

Author information

1
Department of Medical Oncology, National Cancer Institute, Aviano (PN), Italy. mmichieli@cro.it

Abstract

Antiblastic treatment of hematological malignancies during pregnancy poses a number of issues related to the curability of the maternal disease, the need of a prompt treatment and the potential toxicity of chemotherapy for the fetus. Here we report the results of a systematic literature search about the management of the most frequent hematological malignancies that may occur during pregnancy, focusing on specific issues related to gestational age at diagnosis, fetal toxicity and efficacy on the maternal side. The standard approach in non-pregnant women is illustrated as reference.

PMID:
23092517
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center